• Mariela A. Agotegaray
  • Verónica L. Lassalle
Part of the SpringerBriefs in Molecular Science book series (BRIEFSMOLECULAR)


Nanotechnology is a scientific discipline involving multiple hard sciences such as chemistry, physic, biology, engineering, among others. The occurrence of novel properties when materials are reduced to nanosizes is the main reason for the scientific and technological interest in such discipline. In particular nanomedicine, that is nanotechnology applied to medicine, has suffered an exponential grow in the last decades. The possibility to target the drug to the diseased site, by avoiding side effects and lowering the required doses, strongly impulses the development of this kind of technology. Magnetic nanotechnology presents the additional advantage related to nanosystems that may be easily guided by the aid of an external magnetic field. This property improves the targeting capability and increases their potential in biomedical applications such as target drug delivery or MRI diagnostic. Iron oxides based nanosystems are currently the favorites to achieve these kinds of issues due to multiple reasons, but mainly to their low toxicity and biocompatibility. However, surface modification is often required to gain in stability, improve their physicochemical properties or even to raise the reactivity by means of functional groups incorporation. Silica appears as a highly attractive material to assess this objective.

In the Introductory section the general aspects of nanotechnology and nanomedicine are highlighted. Principles of iron oxides nanoparticles and their silica coat are described.


Nanotechnology Nanomedicine Iron oxide Silica Magnetic nanotechnology 


  1. 1.
    Feynman, R. P. (1960). There’s plenty of room at the bottom. Engineering and Science, 23(5), 22–36.Google Scholar
  2. 2.
    Auffan, M., Rose, J., Bottero, J. Y., Lowry, G. V., Jolivet, J. P., & Wiesner, M. R. (2009). Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nature Nanotechnology, 4(10), 634–641.CrossRefGoogle Scholar
  3. 3.
    Zare-Zardini, H., Ferdowsian, F., Soltaninejad, H., Ghorani Azam, A., Soleymani, S., Zare-Shehneh, M., et al. (2016). Application of nanotechnology in biomedicine: A major focus on cancer therapy. Journal of Nano Research, 35, 55–66.CrossRefGoogle Scholar
  4. 4.
    Fahr, A., van Hoogevest, P., May, S., Bergstrand, N., & Leigh, M. L. (2005). Transfer of lipophilic drugs between liposomal membranes and biological interfaces: Consequences for drug delivery. European Journal of Pharmaceutical Sciences, 26(3–4), 251–265.CrossRefGoogle Scholar
  5. 5.
    Yallapu, M. M., Jaggi, M., & Chauhan, S. C. (2012). Curcumin nanoformulations: A future nanomedicine for cancer. Drug Discovery Today, 17(1–2), 71–80.CrossRefGoogle Scholar
  6. 6.
    Bonifácio, B. V., da Silva, P. B., dos Santos Ramos, M. A., Negri, K. M. S., Bauab, T. M., & Chorilli, M. (2014). Nanotechnology-based drug delivery systems and herbal medicines: A review. International Journal of Nanomedicine, 9, 1–15.CrossRefGoogle Scholar
  7. 7.
    Üner, M., & Yener, G. (2007). Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. International Journal of Nanomedicine, 2(3), 289–300.Google Scholar
  8. 8.
    Müller-Goymann, C. C. (2004). Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. European Journal of Pharmaceutics and Biopharmaceutics, 58(2), 343–356.CrossRefGoogle Scholar
  9. 9.
    Abbasi, E., Aval, S. F., Akbarzadeh, A., Milani, M., Nasrabadi, H. T., Joo, S. W., et al. (2014). Dendrimers: Synthesis, applications, and properties. Nanoscale Research Letters, 9(1), 247.CrossRefGoogle Scholar
  10. 10.
    Karimi, M., Solati, N., Amiri, M., Mirshekari, H., Mohamed, E., Taheri, M., et al. (2015). Carbon nanotubes part I: Preparation of a novel and versatile drug-delivery vehicle. Expert Opinion on Drug Delivery, 12(7), 1071–1087.CrossRefGoogle Scholar
  11. 11.
    Al Faraj, A., Shaik, A. P., & Shaik, A. S. (2015). Magnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: Noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarker. International Journal of Nanomedicine, 10, 157.Google Scholar
  12. 12.
    Gulati, K., Kogawa, M., Maher, S., Atkins, G., Findlay, D., & Losic, D. (2015). Titania nanotubes for local drug delivery from implant surfaces. In D. Losic & A. Santos (Eds.), Engineered nanoporous materials (pp. 307–355). New York: Springer International Publishing.Google Scholar
  13. 13.
    Mehra, N. K., & Jain, N. K. (2016). Multifunctional hybrid-carbon nanotubes: New horizon in drug delivery and targeting. Journal of Drug Targeting, 24(4), 294–308.CrossRefGoogle Scholar
  14. 14.
    Modani, S., Kharwade, M., & Nijhawan, M. (2013). Quantum dots: A Novelty of medical fields with multiple applications. International Journal of Current Pharmaceutical Research, 5(4), 55–59.Google Scholar
  15. 15.
    Qi, L., & Gao, X. (2008). Emerging application of quantum dots for drug delivery and therapy. Expert Opinion on Drug Delivery, 5(3), 263–267.CrossRefGoogle Scholar
  16. 16.
    Kim, I. Y., Seo, S. J., Moon, H. S., Yoo, M. K., Park, I. Y., Kim, B. C., Cho, Ch. S. (2008). Chitosan and its derivatives for tissue engineering applications. Biotechnology Advances, 26, 1–21.Google Scholar
  17. 17.
    Varna, M., Ratajczak, P., Ferreira, I., et al. (2012). In vivo distribution of inorganic nanoparticles in preclinical models. Journal of Biomaterials and Nanobiotechnology, 03, 269.CrossRefGoogle Scholar
  18. 18.
    Li, M., Al-Jamal, K. T., Kostarelos, K., et al. (2010). Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano, 4, 6303–6317.CrossRefGoogle Scholar
  19. 19.
    Chono, S., Tanino, T., Seki, T., & Morimoto, K. (2007). Uptake characteristics of liposomes by rat alveolar macrophages: Influence of particle size and surface mannose modification. Journal of Pharmacy and Pharmacology, 59(1), 75–80.CrossRefGoogle Scholar
  20. 20.
    Osaki, F., Kanamori, T., Sando, S., Sera, T., & Aoyama, T. (2004). A quantum dot conjugated sugar ball and its cellular uptake on the size effects of endocytosis in the subviral region. Journal of the American Chemical Society, 126(21), 6520–6521.CrossRefGoogle Scholar
  21. 21.
    Wina, K. Y., & Feng, S. S. (2005). Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26(15), 2713–2722.CrossRefGoogle Scholar
  22. 22.
    Foged, C., Brodin, B., Frokjaer, S., & Sundblad, A. (2005). Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. International Journal of Pharmaceutics, 298(2), 315–322.CrossRefGoogle Scholar
  23. 23.
    Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006). Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Letters, 6(4), 662–668.CrossRefGoogle Scholar
  24. 24.
    Lu, F., Wu, S. H., Hung, Y., & Mou, C. Y. (2009). Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small, 5(12), 1408–1413.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2017

Authors and Affiliations

  • Mariela A. Agotegaray
    • 1
  • Verónica L. Lassalle
    • 1
  1. 1.INQUISUR – CONICETUniversidad Nacional del SurBahía BlancaArgentina

Personalised recommendations